Welcome to RenValueSM
Sanofi is proud to help qualified patients who have prescription insurance or no insurance cover the costs of Renvela® (sevelamer carbonate) tablets and for oral suspension through the RenValue program.
Who can use the RenValue card?

Patients with insurance
· The patient is responsible for the first $5 and the card pays up to the next $300 of the patient's copay.
Example: If you have a copay of $75 you pay $5; if you have a copay of $350 you pay $50.
Patients with no insurance
· Save up to $300 off out-of-pocket costs for each of 12 fills.
* Patients filling prescriptions that are covered by or submitted for reimbursement under Medicaid, Medicare, VA, DOD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance program are not eligible for this offer. This program is not valid where prohibited by law, including in California and Massachusetts.
Example: If your out-of-pocket cost is $400, you pay $100 for each of 12 fills.

Coupon Thumbnail

To print the online RenValue coupon, click here.

To learn more about
Renvela, visit
www.renvela.com

Refill Reminder Thumbnail

Patients who enroll in RenValue can choose from email, text message, or mail to receive refill reminders.


Who cannot use the RenValue card?
Patients filling prescriptions that are covered by or submitted for reimbursement under Medicaid, Medicare, VA, DOD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance program are not eligible for this offer. This program is not valid where prohibited by law, including in California and Massachusetts.

Indication

Renvela® (sevelamer carbonate) is used to control phosphorus levels in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.

Important Safety Information

  • Do not use Renvela if you have a history of bowel obstruction or if you are allergic to sevelamer carbonate, sevelamer hydrochloride or to any of the ingredients in Renvela.
  • Talk to your doctor if you have had difficulty swallowing or swallowing disorders; or if you have had digestive tract surgery or other digestive disorders, including severe constipation.
  • The most frequently occurring side effects with Renvela tablets include nausea and vomiting.
  • Side effects with Renvela powder taken three times a day are similar to those reported for Renvela tablets.
  • The most common side effects with sevelamer include vomiting, nausea, diarrhea, indigestion, abdominal pain, flatulence, and constipation.
  • Cases of itching, rash, fecal impaction and, less commonly, slow bowel activity, bowel obstruction, and bowel perforation have been reported.
  • Uncommon cases of difficulty swallowing the Renvela tablet have been reported. Talk to your doctor if you have difficulty swallowing medicines in tablet form. Renvela for oral suspension may be considered by your doctor if you have a history of difficulty swallowing.
  • Your doctor should monitor your bicarbonate and chloride blood levels.
  • Reduced vitamins D, E, and K (clotting factors) and folic acid blood levels may be followed by your doctor.
  • Talk to your doctor when taking Renvela with other medications.
  • Promptly contact your doctor if you experience severe abdominal pain, new or worsening constipation, or other severe intestinal symptoms while on Renvela.
  • Take Renvela with meals and adhere to your prescribed diet

Please see full Prescribing Information.

If you are a patient experiencing problems with a Sanofi US product while participating in the Renvalue Copay Program, please call Sanofi US at 1-866-257-4605